Atossa Genetics Inc. to Present at Upcoming Investor

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Atossa Genetics Inc. to Present at Upcoming Investor Conferences in October 2016

SEATTLE, WA--(Marketwired - Oct 14, 2016) - Atossa Genetics Inc. ( NASDAQ : ATOS ), today announced it would be a featured presenter at the SeeThru Equity Fall Microcap Investor Conference being held on October 17, 2016 at the Convene, 730 Third Avenue, New York, NY. The Company will also be a featured presenter at the Dawson James Small Cap Growth Conference being held October 20, 2016 at the Wyndham Grand Jupiter at Harbourside Place, Jupiter FL.

Kyle Guse, CFO and General Counsel will discuss the Company's business model and growth strategies at the SeeThru Equity Conference on Monday, October 17, 2016 at 11:30 am Eastern time. Mr. Guse will present at the Dawson James Conference on Thursday, October 20, 2016 at 1:45 pm Eastern time. Mr. Guse will be available for one-on-one investor meetings at both events.

For more information on the SeeThru Equity Fall Microcap Investor Conference please visit: http://www.seethruequity.com/

For more information on the Dawson James Small Cap Growth Conference please visit: http://dawsonjames.com/conference/2015-conferences/

About Atossa Genetics

Atossa Genetics Inc. is a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods to treat breast cancer and other breast conditions. For more information, please visit www.atossagenetics.com .

Forward-Looking Statements

Forward-looking statements in this press release, which Atossa undertakes no obligation to update, are subject to risks and uncertainties that may cause actual results to differ materially from the anticipated or estimated future results, including the risks and uncertainties associated with actions and inactions by the FDA, the outcome or timing of regulatory approvals needed by Atossa, lower than anticipated rate of patient enrollment, results of clinical studies and timing of publication of those results, the safety and efficacy of Atossa's products and services, performance of clinical research organizations and investigators, obstacles resulting from proprietary rights held by others including with respect to Fulvestrant, such as patent rights, and other risks detailed from time to time in Atossa's filings with the Securities and Exchange Commission, including without limitation its periodic reports on Form 10-K and 10-Q, each as amended and supplemented from time to time.

Atossa Genetics Company Contact: Atossa Genetics Inc. Kyle Guse CFO and General Counsel (O) 800-351-3902 kyle.guse@atossagenetics.com Investor Relations Contact Scott Gordon CorProminence LLC 377 Oak Street Concourse 2 Garden City, NY 11530 Office: 516.222.2560 scottg@corprominence.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PAG Secures $355M to Accelerate Aggressive Growth

Updated Category News Views 4

Platform Accounting's Bold Expansion Move When you hear about a $355 million strategic financing round, it paints a picture of company ambitions colored in big, bold strokes. Platform Accounting Group (PAG) has managed to secure such a hefty financial backing from Treville Capital Group, taking a serious shot at expanding its footprint and offerings. This is no small...

Continue Reading
Tutoring America Champions Educational Equity with Grants

Updated Category News Views 7

Bolstering Educational Support for Low-Income Students In a world where opportunities hang on the thread of education, Tutoring America stands as a beacon for those left behind. This nonprofit tackles the education gap head-on, aiming to uplift low-income kids before they hit high school turbulence. Frankly, what they're doing is more than just good work—it's laying the...

Continue Reading
Saddleback's Bold Doula Program: A Game Changer

Updated Category News Views 10

Revolutionizing Maternity Support at Saddleback Saddleback Medical Center in Laguna Hills, California, is stirring the waters with its groundbreaking expansion in maternity services. For the first time, an Orange County hospital—The Women’s Hospital at MemorialCare Saddleback Medical Center—is offering complimentary, around-the-clock in-house doulas. Not a luxury,...

Continue Reading
Hyliion Legal Woes Shake Investor Confidence

Updated Category News Views 6

Legal Storm Brews Over Hyliion Investments If you think riding the stock market is like sailing a calm sea, wake up. Hyliion Holdings Corp. (NYSE:HYLN) finds itself steaming headlong into rough waters. A securities class action lawsuit, Olmeta v. Hyliion Holdings Corp., accuses the company of embellishing its ambitions. The lawsuit cites potential wrongdoing in a...

Continue Reading
JELD-WEN Schedules Q3 2026 Earnings Call Amid Global Reach

Updated Category News Views 4

Looking Ahead: JELD-WEN's Q3 Results Exploration Alright folks, buckle up. JELD-WEN Holding, Inc., the name any DIY'er worth their salt recognizes for doors and windows, has set the stage for unveiling its third quarter 2026 performance. They've earmarked November 3 post-market for us to comb through the numbers, and they're wasting no time by getting on a conference call...

Continue Reading
M&T Bank Declares Quarterly Preferred Dividends

Updated Category News Views 3

No Surprises Here—M&T Pays Out Big On Preferreds If there's one thing the market just loves to see amid all this noise and chatter, it's cash coming back to shareholders. M&T Bank Corporation, a seasoned player in the financial sector, is keeping its shareholders happy with some neat quarterly preferred stock dividends. Now, if you've been poking around the NYSE:MTB...

Continue Reading
IBM Backs Leena AI: Shaping Enterprise Automation

Updated Category News Views 9

IBM's Strategic Bet on Enterprise Automation Diving into the blazing 2026 market, IBM Ventures has thrown its weight behind Leena AI, an enterprise agentic AI firm that's out to shake things up. You see, the name of the game isn't just flashy AI chatbots anymore. Companies like Leena AI are setting their sights on the back-office grunt work—the lifeblood operations in...

Continue Reading
SQUID Platforms on CDAO Tradewinds Marketplace

Updated Category News Views 1

Old School Meets New Tech: SQUID's 'Awardable' Moment In an era drowning in data, IESE Solutions throws us a lifeline with its SQUID platform—assessed 'Awardable' and now live on the Department of War's Chief Digital and Artificial Intelligence Office's (CDAO) Tradewinds Solutions Marketplace. Sounds technical, right? Well, let’s dive into why it matters for those...

Continue Reading
MEDITECH and Lifemed AI Join Forces on Healthcare AI

Updated Category News Views 1

Lifemed AI and MEDITECH: A New Chapter in Healthcare You’d think by now the healthcare systems would be catching a break with technology, but here comes another twist. Lifemed AI and MEDITECH have banded together to tackle the notorious issue of claim denials head-on. Picture this: billions squandered every year because of avoidable administrative slip-ups. That's money...

Continue Reading
ALS.Community Launches Free Online Support Platform

Updated Category News Views 7

A Long Path to Connection Sometimes it's easy to forget the power a community can wield until you see one rally around a cause. The launch of ALS.Community isn't just a digital debut; it's a testament to how collective understanding can be a lifeline. For folks grappling with amyotrophic lateral sclerosis (ALS), beating solitude is often half the battle. Founder Jeff...

Continue Reading

Top 5 Most Recently Viewed Articles

Parkland Corporation Announces Upcoming Dividend Payment Details

Updated Category News Views 94

Parkland Corporation Announces Upcoming Dividend Payment Parkland Corporation (TSX: PKI) has shared some important news for its shareholders regarding the next dividend payment. They plan to distribute a notable dividend of $0.35 per share. This payment is scheduled for October 15, so shareholders should mark their calendars, especially those who are on record by...

Continue Reading
Almirall and Absci Join Forces to Innovate in Dermatology with AI

Updated Category News Views 250

AI-Driven Innovations in Dermatology: Almirall and Absci Collaboration In a significant advancement within the pharmaceutical landscape, Almirall, a prominent biopharmaceutical company, has recently expanded its collaboration with Absci Corporation. This partnership focuses on the innovative use of artificial intelligence (AI) in drug discovery, particularly for...

Continue Reading
PCS Edventures! Unveils Major Share Buyback Initiative

Updated Category News Views 242

PCS Edventures! Announces Share Repurchase Authorization PCS Edventures!, Inc. (OTCPK: PCSV), a prominent provider of K-12 STEM education programs, has recently taken a strategic step by authorizing a substantial share repurchase program. This program allows the company to buy back up to 10 million shares of its common stock within the next three years, which translates...

Continue Reading
Innovative Partnership Aims to Revolutionize Retinal Disease Treatment

Updated Category News Views 282

Innovative Collaboration to Tackle Retinal Diseases Boehringer Ingelheim and Palatin Technologies have taken a monumental step towards addressing retinal diseases by joining forces to create potential first-in-class treatments. This partnership is pivotal in strengthening Boehringer’s diverse pipeline in Eye Health, particularly for conditions such as diabetic...

Continue Reading
Rabbi Dr. Ari Berman's Inspiring Prayer to the U.S. Senate

Updated Category News Views 236

Rabbi Dr. Ari Berman Addresses the U.S. Senate Rabbi Dr. Ari Berman, the esteemed president of Yeshiva University, had the privilege of delivering the opening prayer at the U.S. Senate. This significant moment occurred just before the Jewish High Holidays, highlighting the importance of faith during times of national introspection. An Invitation to Inspire Invited by...

Continue Reading